John Dowling, PA
Physician Assistant · Pittsfield, MANPI 1801277108
Payments from drug & device makers
Across 90 payments — averaging $71.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Senseonics, Incorporated$4K
- Novo Nordisk$415
- Lilly USA, LLC$399
- Insulet Corporation$242
- Medtronic$209
- AstraZeneca$164
- plus $762 from 10 others
What the payments were for
- Speaking & faculty fees$4,24066%
- Food & beverage$2,12133%
- Education$120%
- Gifts$591%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Senseonics, Incorporated | 3 | $4,240 |
| Novo Nordisk | 14 | $415 |
| Lilly USA, LLC | 21 | $399 |
| Insulet Corporation | 2 | $242 |
| Medtronic | 17 | $209 |
| AstraZeneca | 8 | $164 |
| Sanofi-aventis U.S. LLC | 7 | $131 |
| Tandem Diabetes Care, Inc. | 4 | $105 |
| Ascensia Diabetes Care US Inc. | 2 | $99 |
| Amgen | 1 | $95 |
| Dexcom, Inc. | 4 | $83 |
| Abbott | 2 | $76 |
| Mannkind Corporation | 1 | $59 |
| Corcept Therapeutics | 1 | $55 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Boehringer Ingelheim | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,432 in reported general payments places this provider in the 95th percentile of 3,507 physician assistant providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 391 | $412,235 |
| OzempicSemaglutide | 374 | $379,058 |
| MounjaroTirzepatide | 306 | $323,428 |
| JardianceEmpagliflozin | 225 | $238,181 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 189 | $226,724 |
| FarxigaDapagliflozin Propanediol | 147 | $141,342 |
| JanuviaSitagliptin Phosphate | 82 | $86,884 |
| TradjentaLinagliptin | 85 | $73,989 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 73 | $59,392 |
| Humulin R U-500Insulin Regular, Human | 39 | $57,318 |
| WegovySemaglutide | 42 | $56,446 |
| Xultophy 100-3.6Insulin Degludec/Liraglutide | 32 | $47,430 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 103 | $47,211 |
| Bydureon BciseExenatide Microspheres | 43 | $42,871 |
| Tresiba Flextouch U-200Insulin Degludec | 36 | $41,173 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro, Humalog, Baqsimi | $399 | $758,055749 claims |
| Novo NordiskOzempic, Wegovy, Xultophy 100-3.6, Fiasp, Novolog | $415 | $542,018536 claims |
| Boehringer IngelheimJardiance, Tradjenta, Glyxambi, Trijardy Xr | $22 | $373,002374 claims |
| AstraZenecaFarxiga | $164 | $141,342147 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus | $131 | $27,65848 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,507 physician assistant providers in Massachusetts.
Other physician assistant in Pittsfield
- Christopher MasseyWilbraham$190K
- Lizabeth O ConnorEverett$182K
- Kimberly ComeauSwampscott$120K
- Stacey PanasciSpringfield$113K
- Jason RandWaltham$99K
- Karen ChunEast Boston$70K
- David PeckhamQuincy$61K
- Leslie SmithSpringfield$49K
- Andrea MilliganBoston$46K
- Lauren RousseauBoston$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.